{
    "paper_id": "0a32bc60f1b49f12b432564f92c1c39fec6b3477",
    "metadata": {
        "title": "",
        "authors": [
            {
                "first": "B",
                "middle": [],
                "last": "Pozzetto",
                "suffix": "",
                "affiliation": {},
                "email": ":bruno.pozzetto@univ-st-etienne.frb.pozzetto."
            },
            {
                "first": "O",
                "middle": [],
                "last": "Garraud",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [
        {
            "text": "Au cours des 20 derni\u00e8res ann\u00e9es, la s\u00e9curit\u00e9 en transfusion sanguine a fait de tr\u00e8s grands progr\u00e8s vis-\u00e0-vis du risque infectieux et notamment de celui repr\u00e9sent\u00e9 par les r\u00e9trovirus (HIV et HTLV) et les virus des h\u00e9patites B et C. L'objet de cette revue est de r\u00e9pertorier les risques viraux r\u00e9siduels ou \u00e9mergents qui seraient susceptibles d'entra\u00eener de nouvelles contaminations chez les receveurs. \u00c0 c\u00f4t\u00e9 de nombreux autres virus (HHV-8, erythrovirus B19, virus des h\u00e9patites A et E. . .), une place toute particuli\u00e8re est faite aux arboviroses \u00e9mergentes (infections \u00e0 West Nile virus, dengue et chikungunya) qui menacent de toucher le territoire m\u00e9tropolitain suite \u00e0 l'implantation en Europe du moustique Aedes albopictus, principal vecteur de la dengue et du chikungunya dans les r\u00e9gions temp\u00e9r\u00e9es. Un autre risque sanguin \u00e9mergent, particuli\u00e8rement au Royaume-Uni et en France, est constitu\u00e9 par le prion \u00e0 l'origine de la forme variante de la maladie de Creutzfeldt-Jakob. La revue se termine par un rapide panorama des mesures qui sont susceptibles de contr\u00f4ler ces \u00e9mergences : exclusion des donneurs \u00e0 risque, tests diagnostiques sp\u00e9cifiques de tel ou tel agent, d\u00e9leucocytation des produits sanguins labiles et traitements physiques ou chimiques capables d'inactiver de fa\u00e7on non sp\u00e9cifique les agents infectieux potentiellement contaminants sans trop alt\u00e9rer les propri\u00e9t\u00e9s des composants sanguins. La capacit\u00e9 \u00e0 ma\u00eetriser de fa\u00e7on prospective les nouveaux risques viraux au niveau transfusionnel repr\u00e9sente un vrai d\u00e9fi pour pr\u00e9server la confiance retrouv\u00e9e des prescripteurs et des receveurs vis-\u00e0-vis des produits sanguins.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        },
        {
            "text": "During the last 20 years, the safety of blood products increased dramatically with regard to the infectious risk and notably to that represented by retroviruses (HIV and HTLV) and hepatitis B and C viruses. The aim of this review is to identify the residual and emergent viral threats that could be responsible for the occurring of new contaminations in the receivers of blood products. Beside many other viruses (HHV-8, erythrovirus B19, hepatitis A and E viruses. . .), a special attention has been paid to emerging arbovirus diseases (West Nile virus infection, dengue, chikungunya) that threaten to occur in the French metropolitan area following the implantation in Europe of the mosquito Aedes albopictus, the main vector of dengue and chikungunya in temperate regions. Another blood-linked risk, notably in United Kingdom and France, is the prion agent responsible for the variant form of the Creutzfeldt-Jakob disease. The review is concluded by a brief overview of the measures aimed to control these emergences, including the exclusion of at-risk donors, the diagnostic tests able to detect a specific agent, the leukocyte reduction of labile blood products, and the physical or chemical treatments aiming the nonspecific inactivation of infectious agents potentially present in blood without impairing significantly the physiological properties of blood compounds. The ability to control prospectively the new viral risks linked to blood products is a challenge for the preservation of the confidence of both clinicians and receivers in the safety of blood transfusion.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Abstract"
        }
    ],
    "body_text": [
        {
            "text": "Suite aux crises sanitaires suscit\u00e9es par l' \u00ab affaire du sang contamin\u00e9 \u00bb, puis par le \u00ab scandale de l'hormone de croissance \u00bb, les responsables de la transfusion en France se sont dot\u00e9s de moyens de pr\u00e9vention tr\u00e8s performants capables de faire de l'acte transfusionnel l'un des plus s\u00fbrs sous l'angle du risque microbiologique. Gr\u00e2ce \u00e0 la combinaison de diff\u00e9rentes mesures (s\u00e9lection et fid\u00e9lisation des donneurs, d\u00e9leucocytation des produits sanguins, pratique syst\u00e9matique du diagnostic g\u00e9nomique viral pour les virus les plus pathog\u00e8nes. . .), le risque infectieux a \u00e9t\u00e9 r\u00e9duit par un facteur de plus de 1500 au cours des 20 derni\u00e8res ann\u00e9es alors que, dans le m\u00eame temps, le risque d'accident ABO n'a \u00e9t\u00e9 r\u00e9duit que de moiti\u00e9 [1] . Selon des donn\u00e9es r\u00e9centes de l'Institut national de veille sanitaire, le risque r\u00e9siduel moyen d'infection au cours de la p\u00e9riode 2007-2009 serait en France de 1 sur 3 millions de dons pour HIV-1, de 1 sur 6 millions de dons pour HTLV, de 1 sur 10 millions de dons pour le virus de l'h\u00e9patite C (HCV) et de 1 sur 100 000 dons pour le virus de l'h\u00e9patite B (avant instauration du DGV pour ce dernier agent) [2] . Est-ce \u00e0 dire que la question du risque viral vis-\u00e0-vis des produits sanguins labiles (PSL) est d\u00e9finitivement r\u00e9gl\u00e9e en 2011 ? Cela serait sans compter les \u00e9mergences et r\u00e9\u00e9mergences virales qui sont susceptibles de venir compromettre ce fragile \u00e9quilibre et remettre en question la confiance retrouv\u00e9e de l'opinion publique vis-\u00e0-vis de la transfusion. L'objet de la pr\u00e9sente revue est de proposer un \u00e9tat de l'art des risques viraux -auxquels nous associerons les agents transmissibles non conventionnels (ATNC ou prions)-\u00e9mergents qui justifient une veille sanitaire active afin d'anticiper les mesures pouvant pr\u00e9venir de nouvelles infections post-transfusionnelles.",
            "cite_spans": [
                {
                    "start": 734,
                    "end": 737,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 1147,
                    "end": 1150,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "L'Institute of Medicine of the National Academies (\u00c9tats-Unis) a d\u00e9fini une infection \u00e9mergente comme une infection nouvelle, r\u00e9emergente ou r\u00e9sistante aux th\u00e9rapies courantes dont l'incidence chez l'homme a cru au cours des deux derni\u00e8res d\u00e9cennies ou menace de cro\u00eetre au cours des prochaines ann\u00e9es [3] . Le saut d'esp\u00e8ce constitue la modalit\u00e9 la plus embl\u00e9matique d'\u00e9mergence avec apparition d'une nouvelle infection jusquel\u00e0 inconnue (pand\u00e9mie HIV, \u00e9pid\u00e9mie de SARS, variant de la maladie de Creutzfeldt-Jakob [MCJv] . . .) ; la variabilit\u00e9 des virus (et notamment des virus \u00e0 ARN) peut \u00e9galement susciter l'\u00e9mergence d'un nouvel agent viral comme en font foi les diff\u00e9rentes pand\u00e9mies grippales. L'extension d'une infection du fait du d\u00e9placement de son vecteur naturel suite \u00e0 des changements climatiques et \u00e0 l'intensification des d\u00e9placements intercontinentaux est illustr\u00e9e par la diss\u00e9mination r\u00e9cente de plusieurs arboviroses (infections virales transmises par des invert\u00e9br\u00e9s) dans des r\u00e9gions jusque-l\u00e0 \u00e9pargn\u00e9es. Par ailleurs, les nouvelles technologies permettent l'identification de \u00ab nouveaux \u00bb pathog\u00e8nes sans doute pr\u00e9sents depuis tr\u00e8s longtemps mais jusque l\u00e0 m\u00e9connus ; on parle dans ce cas de pseudo-\u00e9mergence dont l'illustration la plus typique est la d\u00e9couverte de HCV, longtemps suspect\u00e9 (agent de l'h\u00e9patite dite non A non B) mais identifi\u00e9 seulement en 1989 gr\u00e2ce \u00e0 l'av\u00e8nement des techniques de biologie mol\u00e9culaire. Enfin, il ne faut pas n\u00e9gliger les (r\u00e9)\u00e9mergences d'origine humaine, qu'elles soient accidentelles (grippe dite russe dans les ann\u00e9es 1970) ou volontaires (bioterrorisme). Le Tableau 1 illustre ces diff\u00e9rentes situations d'\u00e9mergence ou de r\u00e9\u00e9mergence virale avec des exemples emprunt\u00e9s au risque transfusionnel.",
            "cite_spans": [
                {
                    "start": 302,
                    "end": 305,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 515,
                    "end": 521,
                    "text": "[MCJv]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Concept d'\u00e9mergence et de r\u00e9\u00e9mergence virale"
        },
        {
            "text": "Tous les agents infectieux \u00e9mergents ou r\u00e9\u00e9mergents ne pr\u00e9sentent pas le m\u00eame risque pour la transfusion des PSL. Les conditions n\u00e9cessaires (mais pas forc\u00e9ment suffisantes) pour une transmission transfusionnelle sont les suivantes : (i) l'agent doit \u00eatre pr\u00e9sent dans le sang (de fa\u00e7on libre ou associ\u00e9 aux cellules sanguines) \u00e0 un stade de l'infection (plus cette phase est prolong\u00e9e, plus le risque transfusionnel est important) ; (ii) cette phase de pr\u00e9sence sanguine doit co\u00efncider avec une p\u00e9riode asymptomatique ou pauci-symptomatique de l'infection de mani\u00e8re \u00e0 permettre au donneur de passer le filtre de la qualification clinique ; (iii) l'agent infectieux doit \u00eatre dot\u00e9 d'un pouvoir ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conditions pour qu'un agent infectieux constitue un risque transfusionnel"
        },
        {
            "text": "Jusqu'\u00e0 l'\u00e9pid\u00e9mie d'enc\u00e9phalite spongiforme bovine (ESB ou maladie de la vache folle) identifi\u00e9e au Royaume-Uni \u00e0 partir de 1985 et l'adaptation de l'agent causal \u00e0 l'homme, \u00e0 l'origine de la MCJv, les prions humains n'avaient jamais \u00e9t\u00e9 incrimin\u00e9s dans des transmissions par voie sanguine, probablement en raison d'un passage sanguin tr\u00e8s faible, du moins dans les phases pr\u00e9coces de la maladie [6] . La MCJv se caract\u00e9rise au contraire par un tropisme fort de l'agent causal pour les leucocytes et les formations lympho\u00efdes (amygdales, rate, plaques de Payer). Il est impossible de d\u00e9montrer le caract\u00e8re infectieux du sang de sujets atteints de MCJv en l'injectant \u00e0 des petits animaux de laboratoires, probablement en raison des charges infectieuses trop faibles et de la barri\u00e8re g\u00e9n\u00e9tique ; en revanche, par l'utilisation de souches variantes de prions adapt\u00e9es au hamster ou \u00e0 la souris, il a \u00e9t\u00e9 montr\u00e9 que l'inoculation par voie sanguine \u00e9tait aussi efficace que celle par voie intrac\u00e9r\u00e9brale et que l'infectiosit\u00e9 du sang total se r\u00e9partissait pour 40 % sur les leucocytes (avec possibilit\u00e9 de relarguer une grande partie de ces prions par lavage des cellules) et pour le reste dans le plasma [7] .",
            "cite_spans": [
                {
                    "start": 397,
                    "end": 400,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 1204,
                    "end": 1207,
                    "text": "[7]",
                    "ref_id": "BIBREF6"
                }
            ],
            "ref_spans": [],
            "section": "Variante de la maladie de Creutzfeldt-Jakob"
        },
        {
            "text": "D\u00e8s 2002, des \u00e9tudes exp\u00e9rimentales chez le mouton infect\u00e9 par une souche de prion provenant d'une vache atteinte d'ESB ont montr\u00e9 que cet agent pouvait \u00eatre transmis par voie sanguine \u00e0 un autre animal d\u00e8s la phase d'incubation de la maladie [8] . Gr\u00e2ce \u00e0 une surveillance syst\u00e9matique des patients ayant re\u00e7u des PSL de sujets identifi\u00e9s secondairement comme atteint de MCJv au Royaume-Uni, le premier cas humain av\u00e9r\u00e9 de transmission sanguine de prion a \u00e9t\u00e9 identifi\u00e9 en 2002 [9] ; trois autres cas ont \u00e9t\u00e9 d\u00e9crits par la suite [10] [11] [12] . Trois des quatre cas publi\u00e9s se sont manifest\u00e9s par des tableaux de MCJv dans un d\u00e9lai de six \u00e0 8,5 ans apr\u00e8s la transfusion ; ils \u00e9taient tous homozygotes MM au codon 129 du g\u00e8ne prp (le support g\u00e9n\u00e9tique de la prot\u00e9ine humaine capable de se commuter en prion), comme l'ensemble des patients atteints de MCJv identifi\u00e9s \u00e0 ce jour. En revanche, le deuxi\u00e8me patient est d\u00e9c\u00e9d\u00e9 d'une pathologie intercurrente cinq ans apr\u00e8s la transfusion \u00e0 risque [10] ; \u00e0 l'autopsie, le prion variant a \u00e9t\u00e9 retrouv\u00e9 dans le syst\u00e8me lympho\u00efde mais pas dans le cerveau ; or ce patient \u00e9tait h\u00e9t\u00e9rozygote MV au codon 129, ce qui est actuellement consid\u00e9r\u00e9 comme un facteur de protection ou au moins de retard pour le d\u00e9veloppement d'une MCJv. Enfin, il est important de noter que ces quatre patients avaient tous re\u00e7u des PSL non d\u00e9leucocyt\u00e9s.",
            "cite_spans": [
                {
                    "start": 243,
                    "end": 246,
                    "text": "[8]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 479,
                    "end": 482,
                    "text": "[9]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 531,
                    "end": 535,
                    "text": "[10]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 536,
                    "end": 540,
                    "text": "[11]",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 541,
                    "end": 545,
                    "text": "[12]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 994,
                    "end": 998,
                    "text": "[10]",
                    "ref_id": "BIBREF9"
                }
            ],
            "ref_spans": [],
            "section": "Variante de la maladie de Creutzfeldt-Jakob"
        },
        {
            "text": "Au Royaume-Uni, le risque de transmission est estim\u00e9 autour de 1 pour 15 000 \u00e0 30 000 dons [9] . En France, o\u00f9 le nombre total de cas de MCJv est dix \u00e0 20 fois plus faible qu'au Royaume-Uni, trois donneurs de sang ont \u00e9t\u00e9 identifi\u00e9s secondairement comme atteints de MCJv ; aucune transmission n'a \u00e9t\u00e9 signal\u00e9e \u00e0 ce jour chez les 16 receveurs encore en vie en 2009 [6] . Le risque r\u00e9siduel en France serait de l'ordre de 1 pour 360000 dons [6] ; la d\u00e9leucocytation des PSL (voir ci-dessous) et l'exclusion du don de sang des sujets pr\u00e9alablement transfus\u00e9s ont constitu\u00e9 deux mesures importantes pour r\u00e9duire ce risque.",
            "cite_spans": [
                {
                    "start": 91,
                    "end": 94,
                    "text": "[9]",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 364,
                    "end": 367,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 439,
                    "end": 442,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "Variante de la maladie de Creutzfeldt-Jakob"
        },
        {
            "text": "La maladie du d\u00e9p\u00e9rissement chronique des cervid\u00e9s est une affection \u00e0 prions qui s\u00e9vit dans les for\u00eats du nord des \u00c9tats-Unis et du Canada. Bien que cette pathologie n'affecte que les daims et les cerfs et qu'aucun cas humain n'ait jamais \u00e9t\u00e9 d\u00e9crit, bien des incertitudes subsistent sur son \u00e9pid\u00e9miologie et sa physiopathologie. Un saut de barri\u00e8re d'esp\u00e8ce ne pouvant \u00eatre \u00e9cart\u00e9, les responsables de la transfusion en Am\u00e9rique du Nord restent en alerte par rapport \u00e0 cette \u00e9pizootie.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Chronic wasting disease (CWD)"
        },
        {
            "text": "Les arbovirus (ARthropod BOrne VIRUSes) correspondent \u00e0 un groupe de virus de diff\u00e9rentes familles partageant la propri\u00e9t\u00e9 d'\u00eatre tous transmis par des invert\u00e9br\u00e9s. Le Tableau 3 pr\u00e9sente les cinq arboviroses les plus pr\u00e9occupantes en transfusion sanguine.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Arboviroses"
        },
        {
            "text": "Depuis l'\u00e9mergence de cette arbovirose en Am\u00e9rique du Nord entre 1999 et 2005, l'infection \u00e0 WNV constitue le prototype de la pathologie vectorielle susceptible de se transmettre par les PSL et les tissus. End\u00e9mique ou \u00e9pid\u00e9mique dans de nombreuses r\u00e9gions du globe, cette pathologie n'a r\u00e9v\u00e9l\u00e9 sa capacit\u00e9 \u00e0 se transmettre autrement que par des moustiques qu'en 2002 avec la description, au cours de l'\u00e9pid\u00e9mie nord-am\u00e9ricaine, de cas d'infections graves suite \u00e0 la transfusion de d\u00e9riv\u00e9s sanguins ou \u00e0 une transplantation d'organe [13, 14] . Pour limiter ce risque nosocomial, les autorit\u00e9s de sant\u00e9 nord-am\u00e9ricaines ont pr\u00e9conis\u00e9 une recherche d'anticorps et un diagnostic g\u00e9nomique viral chez tous les donneurs, soit en minipools, soit en individuel dans les zones de forte end\u00e9mie. Cette strat\u00e9gie relativement co\u00fbt-efficace au d\u00e9but de l'\u00e9pid\u00e9mie (incidence de dons d\u00e9pist\u00e9s positifs : 1,4 sur 10 000 en 2003, 0,44 sur 10 000 en 2004) [5] est remise en question du fait du caract\u00e8re d\u00e9sormais end\u00e9mique de l'infection \u00e0 WNV : en effet, le co\u00fbt d'une ann\u00e9e de vie gagn\u00e9e par cette strat\u00e9gie, ajust\u00e9e sur la qualit\u00e9 de vie (indicateur QALY), a \u00e9t\u00e9 \u00e9valu\u00e9e \u00e0 1,5 million de dollars [15] . Tableau 2 Classification des risques infectieux \u00e9mergents en mati\u00e8re de s\u00e9curit\u00e9 transfusionnelle selon l'AABB (American Association of Blood Banks) en 2009 [5] . Il est important de noter que cette priorisation a \u00e9t\u00e9 \u00e9tablie pour les risques sp\u00e9cifiques \u00e0 l'Am\u00e9rique du Nord. [16] ; si cette situation venait \u00e0 se reproduire, les \u00e9tablissements transfusionnels concern\u00e9s sont op\u00e9rationnels pour mettre en place un diagnostic g\u00e9nomique viral.",
            "cite_spans": [
                {
                    "start": 533,
                    "end": 537,
                    "text": "[13,",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 538,
                    "end": 541,
                    "text": "14]",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 941,
                    "end": 944,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1185,
                    "end": 1189,
                    "text": "[15]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 1192,
                    "end": 1201,
                    "text": "Tableau 2",
                    "ref_id": null
                },
                {
                    "start": 1349,
                    "end": 1352,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1469,
                    "end": 1473,
                    "text": "[16]",
                    "ref_id": "BIBREF15"
                }
            ],
            "ref_spans": [],
            "section": "Infection \u00e0 virus West Nile"
        },
        {
            "text": "La dengue repr\u00e9sente sans doute une des priorit\u00e9s \u00e0 venir en mati\u00e8re de risque viral transfusionnel \u00e9mergent : (i) plus de 100 millions de cas sont r\u00e9pertori\u00e9s dans le monde dont 250 000 formes h\u00e9morragiques graves ; (ii) la zone de diffusion de la maladie ne cesse de s'\u00e9tendre, notamment en raison de l'extension de la zone d'influence d'Aedes albopictus, l'un des vecteurs du virus de la dengue (DEN-V) ; (iii) il existe quatre s\u00e9rotypes de DEN-V et l'infection par un s\u00e9rotype ne prot\u00e8ge pas contre les trois autres ; (iv) les vir\u00e9mies mesur\u00e9es chez les donneurs de sang peuvent \u00eatre \u00e9lev\u00e9es de l'ordre de 10 5 \u00e0 10 7 ufp/ml [17, 18] , et la dur\u00e9e de la vir\u00e9mie est de l'ordre d'une semaine ; (v) il a enfin \u00e9t\u00e9 publi\u00e9 r\u00e9cemment quatre cas de transmission sanguine av\u00e9r\u00e9e suite \u00e0 des transfusions de PSL [19] [20] [21] . Le faible nombre de cas transfusionnels rapport\u00e9s en regard du nombre consid\u00e9rable d'infections chaque ann\u00e9e est sans doute \u00e0 relier au fait que l'infection touche essentiellement les zones intertropicales o\u00f9 l'incidence \u00e9lev\u00e9e de l'infection naturelle masque les cas transfusionnels et que beaucoup de formes post-transfusionnelles sont \u00e9galement asymptomatiques (contrairement \u00e0 l'infection par le WNV, l'immunosuppression ne semble pas favoriser les cas graves).",
            "cite_spans": [
                {
                    "start": 629,
                    "end": 633,
                    "text": "[17,",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 634,
                    "end": 637,
                    "text": "18]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 808,
                    "end": 812,
                    "text": "[19]",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 813,
                    "end": 817,
                    "text": "[20]",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 818,
                    "end": 822,
                    "text": "[21]",
                    "ref_id": "BIBREF20"
                }
            ],
            "ref_spans": [],
            "section": "Dengue"
        },
        {
            "text": "Deux faits \u00e9pid\u00e9miologiques importants en relation avec la dengue ont concern\u00e9 la France en 2010 : d'une part, une importante \u00e9pid\u00e9mie, principalement \u00e0 s\u00e9rotype 1, a \u00e9t\u00e9 observ\u00e9e dans les Antilles (Martinique, Guadeloupe, Saint-Martin, Saint-Barth\u00e9lemy) au cours de l'\u00e9t\u00e9 [22] , au moins comparable \u00e0 celle de 2007 ; d'autre part, deux cas autochtones ont \u00e9t\u00e9 rapport\u00e9s \u00e0 Nice en septembre [23] : ce sont les premiers cas non import\u00e9s de la zone Europe dus \u00e0 cet agent. En dehors de mesures d'exclusion en p\u00e9riode \u00e9pid\u00e9mique, il n'existe aucune action sp\u00e9cifique pour pr\u00e9venir la dengue transfusionnelle et notamment pas de test commercial de diagnostic g\u00e9nomique viral. Une r\u00e9flexion est engag\u00e9e pour renforcer la surveillance si le virus venait \u00e0 s'implanter durablement sur le territoire m\u00e9tropolitain.",
            "cite_spans": [
                {
                    "start": 273,
                    "end": 277,
                    "text": "[22]",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 391,
                    "end": 395,
                    "text": "[23]",
                    "ref_id": "BIBREF22"
                }
            ],
            "ref_spans": [],
            "section": "Dengue"
        },
        {
            "text": "L'\u00e9pid\u00e9mie de CHIK-V qui a s\u00e9vi sur l'\u00eele de la R\u00e9union entre 2005 et 2006 constitue une autre illustration d'\u00e9mergence particuli\u00e8rement r\u00e9ussie. Le 20 janvier 2006, face \u00e0 l'ampleur de l'\u00e9pid\u00e9mie (avec 10 000 \u00e0 40 000 nouveaux cas par semaine), l'\u00c9tablissement fran\u00e7ais du sang a suspendu la collecte de sang total sur l'\u00eele et a mis en place deux mesures qui n'avaient jamais \u00e9t\u00e9 exp\u00e9riment\u00e9es \u00e0 grande \u00e9chelle pour les dons de plaquettes : qualification unitaire par RT-PCR quantitative et inactivation syst\u00e9matique des concentr\u00e9s plaquettaires par le syst\u00e8me Intercept \u00ae susceptible de r\u00e9duire de plus de 5 log 10 la charge virale d'un produit sanguin. Selon une mod\u00e9lisation de l'Institut national de veille sanitaire (INVS), en consid\u00e9rant que la dur\u00e9e moyenne de la vir\u00e9mie est de 7,5 jours et que 38 % de la population r\u00e9unionnaise a \u00e9t\u00e9 expos\u00e9e au virus (dont environ 6 % de formes asymptomatiques), le nombre de dons positifs \u00e9vit\u00e9s a \u00e9t\u00e9 de 29 au pic de l'\u00e9pid\u00e9mie et de 40 pour l'ensemble de celle-ci [24] .",
            "cite_spans": [
                {
                    "start": 1013,
                    "end": 1017,
                    "text": "[24]",
                    "ref_id": "BIBREF23"
                }
            ],
            "ref_spans": [],
            "section": "Chikungunya"
        },
        {
            "text": "En d\u00e9finitive, aucun cas de contamination transfusionnelle n'a \u00e9t\u00e9 r\u00e9ellement observ\u00e9 ni \u00e0 la R\u00e9union ni ailleurs dans le monde. Pourtant le risque de transmission sanguine est av\u00e9r\u00e9 par plusieurs cas de contaminations de travailleurs de laboratoires et par un cas de contamination d'une infirmi\u00e8re au cours d'un pr\u00e9l\u00e8vement de sang chez un patient infect\u00e9 [25, 26] .",
            "cite_spans": [
                {
                    "start": 357,
                    "end": 361,
                    "text": "[25,",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 362,
                    "end": 365,
                    "text": "26]",
                    "ref_id": "BIBREF25"
                }
            ],
            "ref_spans": [],
            "section": "Chikungunya"
        },
        {
            "text": "L'\u00e9pid\u00e9mie de chikungunya continue de d\u00e9ferler vers l'Est (Inde, Indon\u00e9sie, Malaisie, Sri Lanka, Singapour. . .) avec un tr\u00e8s grand nombre de formes symptomatiques, mais sans manifestations tr\u00e8s graves, contrairement aux deux arboviroses pr\u00e9c\u00e9dentes. Au cours de l'\u00e9t\u00e9 2007, un foyer de 250 cas a \u00e9t\u00e9 observ\u00e9 dans la province de Ravenne, au nord-est de l'Italie, suite au retour d'Inde d'un voyageur infect\u00e9 lors d'une piq\u00fbre de moustique dans ce pays [27] .",
            "cite_spans": [
                {
                    "start": 452,
                    "end": 456,
                    "text": "[27]",
                    "ref_id": "BIBREF26"
                }
            ],
            "ref_spans": [],
            "section": "Chikungunya"
        },
        {
            "text": "En septembre 2010, les deux premiers cas fran\u00e7ais non import\u00e9s de chikungunya ont \u00e9t\u00e9 rapport\u00e9s chez des adolescentes de la r\u00e9gion de Fr\u00e9jus [23] .",
            "cite_spans": [
                {
                    "start": 141,
                    "end": 145,
                    "text": "[23]",
                    "ref_id": "BIBREF22"
                }
            ],
            "ref_spans": [],
            "section": "Chikungunya"
        },
        {
            "text": "Suite \u00e0 des importations en provenance d'Asie de pneumatiques rechap\u00e9s charg\u00e9s de larves, le vecteur Aedes albopictus est d\u00e9sormais largement implant\u00e9 sur tout le pourtour m\u00e9diterran\u00e9en (sa zone d'influence en France s'\u00e9tend jusqu'\u00e0 Montpellier \u00e0 l'est et \u00e0 l'agglom\u00e9ration lyonnaise au nord), cr\u00e9ant une situation propice \u00e0 la diffusion de CHIK-V comme de DEN-V en cas d'importation de ces agents par le biais de sujets infect\u00e9s. Concernant la surveillance entomologique pratiqu\u00e9e suite aux cas autochtones de dengue et de chikungunya survenus presque simultan\u00e9ment dans deux zones voisines du sud-est de la France en septembre 2010, il est int\u00e9ressant de noter que seulement deux moustiques ont \u00e9t\u00e9 trouv\u00e9s infect\u00e9s par CHIK-V alors que 180 \u00e9taient infect\u00e9s par DEN-V, ce qui montre le caract\u00e8re bien plus \u00e9pid\u00e9miog\u00e8ne du premier virus que du second.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Chikungunya"
        },
        {
            "text": "Les principaux arbovirus pr\u00e9sentant un risque transfusionnel potentiel ou av\u00e9r\u00e9s sont pr\u00e9sent\u00e9s dans le Tableau 3. Pour les \u00c9tats-Unis, l'enc\u00e9phalite de Saint-Louis constitue une pr\u00e9occupation importante en raison de la gravit\u00e9 de certaines formes neurologiques. Bien qu'il n'existe aucun cas d\u00e9crit de transmission transfusionnelle, la proximit\u00e9 phylog\u00e9n\u00e9tique de ce virus avec WNV et leurs similitudes \u00e9pid\u00e9miologiques (m\u00eame vecteur, m\u00eame r\u00e9servoir aviaire, m\u00eames h\u00f4tes accidentels : homme et cheval) plaident pour une vigilance autour de cet agent.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Autres arboviroses"
        },
        {
            "text": "L'enc\u00e9phalite \u00e0 tique s\u00e9vit dans toute l'Europe centrale (y compris l'Alsace pour la France, l'Allemagne, la Suisse et l'Autriche), la Russie et l'Asie (jusqu'au Japon). Des cas posttransfusionnels ont \u00e9t\u00e9 d\u00e9crits en Finlande [28] . Un vaccin est disponible dans les r\u00e9gions de forte end\u00e9mie.",
            "cite_spans": [
                {
                    "start": 226,
                    "end": 230,
                    "text": "[28]",
                    "ref_id": "BIBREF27"
                }
            ],
            "ref_spans": [],
            "section": "Autres arboviroses"
        },
        {
            "text": "HHV-8 est l'agent causal du sarcome de Kaposi. Il se transmet principalement par voie sexuelle et sa pr\u00e9valence a \u00e9t\u00e9 estim\u00e9e entre 2 et 4 % chez les donneurs de sang aux \u00c9tats-Unis et \u00e0 2 % chez les donneurs fran\u00e7ais [29, 30] . Sa transmission par voie sanguine a \u00e9t\u00e9 discut\u00e9e au cours d'une transfusion de sang et d'une transplantation r\u00e9nale [31, 32] ; elle a \u00e9t\u00e9 bien \u00e9tablie par une \u00e9tude prospective men\u00e9e au Kenya et ayant montr\u00e9 un taux de s\u00e9roconversion, dans un d\u00e9lai de trois \u00e0 dix semaines apr\u00e8s un acte transfusionnel, significativement plus \u00e9lev\u00e9 dans le groupe transfus\u00e9 que dans le groupe non transfus\u00e9 [33] . Cependant, aucune infection clinique n'a \u00e9t\u00e9 observ\u00e9e. Cette derni\u00e8re observation, conjugu\u00e9e \u00e0 la faible incidence du portage, a conduit \u00e0 ne prendre aucune mesure particuli\u00e8re de pr\u00e9vention en dehors de la d\u00e9leucocytation des PSL [3] .",
            "cite_spans": [
                {
                    "start": 218,
                    "end": 222,
                    "text": "[29,",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 223,
                    "end": 226,
                    "text": "30]",
                    "ref_id": "BIBREF29"
                },
                {
                    "start": 345,
                    "end": 349,
                    "text": "[31,",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 350,
                    "end": 353,
                    "text": "32]",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 619,
                    "end": 623,
                    "text": "[33]",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 857,
                    "end": 860,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [],
            "section": "Human herpes virus 8 (HHV-8)"
        },
        {
            "text": "Ce petit virus non envelopp\u00e9, tr\u00e8s r\u00e9sistant dans le milieu ext\u00e9rieur et responsable du m\u00e9gal\u00e9ryth\u00e8me \u00e9pid\u00e9mique chez l'enfant, d'infections cong\u00e9nitales par transmission transplacentaire et de pouss\u00e9es de d\u00e9globulinisation aigu\u00ebs chez les sujets porteurs d'an\u00e9mies constitutionnelles, a un fort tropisme pour les cellules my\u00e9lo\u00efdes. En raison de sa grande r\u00e9sistance, notamment aux traitements par solvant-d\u00e9tergent, il contamine pr\u00e9f\u00e9rentiellement les produits sanguins stables [34] [35] [36] . La plupart des fabricants de ces produits utilisent des tests mol\u00e9culaires pour exclure les produits contamin\u00e9s par cet agent [3] .",
            "cite_spans": [
                {
                    "start": 480,
                    "end": 484,
                    "text": "[34]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 485,
                    "end": 489,
                    "text": "[35]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 490,
                    "end": 494,
                    "text": "[36]",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 623,
                    "end": 626,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                }
            ],
            "ref_spans": [],
            "section": "Erythrovirus B19 (ex-parvovirus B19)"
        },
        {
            "text": "Ces deux agents non envelopp\u00e9s, principalement diss\u00e9min\u00e9s par voie f\u00e9cale-orale, pr\u00e9sentent une courte vir\u00e9mie au cours de laquelle ils peuvent \u00eatre transmis par transfusion [37] [38] [39] [40] [41] . Les infections sont habituellement asymptomatiques chez le receveur. N\u00e9anmoins, HEV est end\u00e9mique en France, notamment dans le r\u00e9servoir porcin, et l'infection par cet agent, potentiellement grave chez l'immunod\u00e9prim\u00e9 (par exemple apr\u00e8s transplantation h\u00e9patique ou r\u00e9nale) et la femme enceinte, est consid\u00e9r\u00e9e comme \u00e9mergente (pour des revues sur cet agent, voir [42, 43] ). C'est pourquoi une vigilance est de rigueur vis-\u00e0-vis du risque transfusionnel, notamment chez des sujets transplant\u00e9s [44] [45] [46] .",
            "cite_spans": [
                {
                    "start": 174,
                    "end": 178,
                    "text": "[37]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 179,
                    "end": 183,
                    "text": "[38]",
                    "ref_id": "BIBREF37"
                },
                {
                    "start": 184,
                    "end": 188,
                    "text": "[39]",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 189,
                    "end": 193,
                    "text": "[40]",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 194,
                    "end": 198,
                    "text": "[41]",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 565,
                    "end": 569,
                    "text": "[42,",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 570,
                    "end": 573,
                    "text": "43]",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 696,
                    "end": 700,
                    "text": "[44]",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 701,
                    "end": 705,
                    "text": "[45]",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 706,
                    "end": 710,
                    "text": "[46]",
                    "ref_id": "BIBREF45"
                }
            ],
            "ref_spans": [],
            "section": "Virus de l'h\u00e9patite A (HAV) et de l'h\u00e9patite E (HEV)"
        },
        {
            "text": "Les virus HIV-1 et HBV se caract\u00e9risent par leur capacit\u00e9 \u00e0 \u00e9voluer sous forme de quasi-esp\u00e8ce caract\u00e9ris\u00e9e par l'\u00e9mergence de mutants au fil de l'histoire clinique du patient. Certaines mutations peuvent s'accompagner d'une non-reconnaissance par les tests diagnostiques traditionnels [47] . Pour l'HBV, il existe en outre des cas d'h\u00e9patite B dite occulte o\u00f9 seuls les marqueurs mol\u00e9culaires sont positifs [48, 49] . Le diagnostic g\u00e9nomique viral appliqu\u00e9 \u00e0 tous les dons de sang pour la d\u00e9tection du g\u00e9nome de ces deux agents (en combinaison avec celui de HCV) est susceptible de r\u00e9duire consid\u00e9rablement les risques de fauxn\u00e9gatif par les tests s\u00e9rologiques.",
            "cite_spans": [
                {
                    "start": 286,
                    "end": 290,
                    "text": "[47]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 408,
                    "end": 412,
                    "text": "[48,",
                    "ref_id": null
                },
                {
                    "start": 413,
                    "end": 416,
                    "text": "49]",
                    "ref_id": "BIBREF48"
                }
            ],
            "ref_spans": [],
            "section": "Variants de HIV-1 et de HBV"
        },
        {
            "text": "Le variant grippal A/H5N1 qui est responsable d'une v\u00e9ritable pand\u00e9mie aviaire depuis une dizaine d'ann\u00e9e a caus\u00e9 \u00e0 ce jour plus de 500 infections humaines document\u00e9es virologiquement, avec une mortalit\u00e9 d'environ 60 % [50] . Malgr\u00e9 ces chiffres alarmants, il s'agit essentiellement de transmissions directes de l'animal \u00e0 l'homme. Le sc\u00e9nario d'une adaptation durable du virus \u00e0 notre esp\u00e8ce justifie une vigilance extr\u00eame. M\u00eame si la dur\u00e9e tr\u00e8s courte de la vir\u00e9mie ne semble pas faire peser un risque important sur l'acte transfusionnel [51] , la d\u00e9sorganisation de la transfusion sanguine provoqu\u00e9e par une pand\u00e9mie grippale de tr\u00e8s grandes ampleur et gravit\u00e9 a \u00e9t\u00e9 anticip\u00e9e dans les \u00ab plans pand\u00e9miques \u00bb pr\u00e9par\u00e9s par de nombreux pays [3, 52] .",
            "cite_spans": [
                {
                    "start": 219,
                    "end": 223,
                    "text": "[50]",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 540,
                    "end": 544,
                    "text": "[51]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 741,
                    "end": 744,
                    "text": "[3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 745,
                    "end": 748,
                    "text": "52]",
                    "ref_id": "BIBREF51"
                }
            ],
            "ref_spans": [],
            "section": "Virus grippal A/H5N1"
        },
        {
            "text": "Des chasseurs ou des personnes expos\u00e9s professionnellement \u00e0 des primates non humains ont \u00e9t\u00e9 identifi\u00e9s comme porteurs d'anticorps contre certains r\u00e9trovirus simiens et notamment le Simian foamy virus (SFV) [53] . Par ailleurs, le d\u00e9veloppement d'un tourisme de masse dans des r\u00e9gions exotiques o\u00f9 vivent des singes h\u00e9bergeant de nombreux r\u00e9trovirus constitue un risque de contamination accidentelle non n\u00e9gligeable : le risque d'infection par SFV a \u00e9t\u00e9 estim\u00e9 \u00e0 0,3 % pour les quelque 700 000 touristes visitant chaque ann\u00e9e les r\u00e9serves de singes de l'\u00eele de Bali [54] . M\u00eame s'il n'a jamais \u00e9t\u00e9 rapport\u00e9 de transmission transfusionnelle de cet agent, il ne faut pas n\u00e9gliger, par analogie avec l'origine simienne de la pand\u00e9mie HIV, l'hypoth\u00e8se de son adaptation durable \u00e0 l'esp\u00e8ce humaine, ce qui ne manquerait pas d'impacter la s\u00e9curit\u00e9 transfusionnelle.",
            "cite_spans": [
                {
                    "start": 208,
                    "end": 212,
                    "text": "[53]",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 567,
                    "end": 571,
                    "text": "[54]",
                    "ref_id": "BIBREF53"
                }
            ],
            "ref_spans": [],
            "section": "R\u00e9trovirus simiens"
        },
        {
            "text": "La liste des virus poss\u00e9dant un risque transfusionnel th\u00e9orique pourrait s'allonger presqu'ind\u00e9finiment tant sont nombreux les virus transmissibles par voie sanguine, qu'il s'agisse des centaines d'esp\u00e8ces d'arbovirus infestant la plan\u00e8te, des papillomavirus, du coronavirus du SRAS (dont la circulation a compl\u00e8tement cess\u00e9 apr\u00e8s une br\u00e8ve \u00e9mergence en 2002-2003), du virus de la variole (qui pourrait \u00eatre \u00ab ressuscit\u00e9 \u00bb dans le cadre d'une op\u00e9ration de bioterrorisme), des virus des fi\u00e8vres h\u00e9morragiques (Ebola, Lassa, Marburg, ar\u00e9navirus du nouveau monde, fi\u00e8vre de la vall\u00e9e du Rift, fi\u00e8vre jaune, fi\u00e8vre h\u00e9morragique d'Omsk, fi\u00e8vre h\u00e9morragique de Crim\u00e9e-Congo, maladie de la for\u00eat de Kyasanur), voire de virus actuellement orphelins de pouvoir pathog\u00e8ne comme GBVc/HGV ou TTV/SEN-V.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Autres virus"
        },
        {
            "text": "Outre les mesures non sp\u00e9cifiques de s\u00e9lection clinique des donneurs et d'exclusion de ceux pr\u00e9sentant des risques potentiels, notamment suite \u00e0 un retour de zone \u00e0 risque, la s\u00e9curit\u00e9 virale des PSL repose principalement sur trois types de mesures : (i) les tests biologiques cibl\u00e9s de d\u00e9pistage de certains virus, (ii) la d\u00e9leucocytation des PSL et (iii) la mise en oeuvre de techniques d'inactivation large des pathog\u00e8nes. Ces trois types de mesures sont \u00e9voqu\u00e9s bri\u00e8vement ci-dessous.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "N\u00e9cessit\u00e9 de mesures de contr\u00f4les"
        },
        {
            "text": "Ces tests sont principalement d\u00e9di\u00e9s aux virus \u00ab majeurs \u00bb (HIV, HBV, HCV, HTLV). D'abord de type immunologique (avec d\u00e9tection d'anticorps et, si possible, d'antig\u00e8nes s\u00e9riques), ils sont \u00e9galement mol\u00e9culaires (diagnostic g\u00e9nomique viral) en France pour HIV, HCV et, r\u00e9cemment, HBV. Ces derniers permettent de r\u00e9duire la fen\u00eatre s\u00e9rologique et d'\u00e9largir le d\u00e9pistage aux virus variants non reconnus par les tests immunologiques. Un article r\u00e9cent [55] vient de montrer l'apport de la d\u00e9tection mol\u00e9culaire de HBV chez les donneurs de sang (y compris ceux vaccin\u00e9s contre l'h\u00e9patite B) pour pr\u00e9venir la contamination des receveurs par de telles souches variantes.",
            "cite_spans": [
                {
                    "start": 449,
                    "end": 453,
                    "text": "[55]",
                    "ref_id": "BIBREF54"
                }
            ],
            "ref_spans": [],
            "section": "Tests biologiques cibl\u00e9s de d\u00e9pistage"
        },
        {
            "text": "De nombreux virus \u00e9mergents peuvent \u00eatre identifi\u00e9s par des tests sp\u00e9cifiques, qu'ils soient s\u00e9rologiques ou mol\u00e9culaires. Ainsi, un diagnostic g\u00e9nomique viral pour le WNV a \u00e9t\u00e9 instaur\u00e9 en Am\u00e9rique du Nord d\u00e8s l'\u00e9mergence des premiers cas transfusionnels identifi\u00e9s dans ce sous-continent. Lors de l'\u00e9pid\u00e9mie de CHIK-V \u00e0 la R\u00e9union, un diagnostic g\u00e9nomique viral a \u00e9t\u00e9 instaur\u00e9 chez les donneurs autochtones de plaquettes. A priori, n'importe quel agent \u00e9mergent peut faire l'objet d'un tel d\u00e9pistage. En pratique, il faut n\u00e9anmoins \u00eatre capable d'adapter la technique (parfois r\u00e9serv\u00e9e \u00e0 des centres de r\u00e9f\u00e9rence) \u00e0 un d\u00e9pistage de masse, ce qui ne va pas sans poser des probl\u00e8mes \u00e0 la fois organisationnels et \u00e9conomiques [15] .",
            "cite_spans": [
                {
                    "start": 725,
                    "end": 729,
                    "text": "[15]",
                    "ref_id": "BIBREF14"
                }
            ],
            "ref_spans": [],
            "section": "Tests biologiques cibl\u00e9s de d\u00e9pistage"
        },
        {
            "text": "Pour le prion responsable de la MCJv, des tests biologiques sont en cours de d\u00e9veloppement, mais leur manque de sensibilit\u00e9 et l'absence de test de confirmation standardis\u00e9 rendent leur mise en oeuvre encore hasardeuse [6] . La publication toute r\u00e9cente d'un test capable de d\u00e9tecter l'agent variant de la MCJv dans le sang de sujets atteints de cette pathologie [56] laisse esp\u00e9rer que nous disposerons dans le futur d'un test suffisamment sensible pour \u00eatre utilis\u00e9 en d\u00e9pistage transfusionnel de routine.",
            "cite_spans": [
                {
                    "start": 219,
                    "end": 222,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 363,
                    "end": 367,
                    "text": "[56]",
                    "ref_id": "BIBREF55"
                }
            ],
            "ref_spans": [],
            "section": "Tests biologiques cibl\u00e9s de d\u00e9pistage"
        },
        {
            "text": "La mesure a \u00e9t\u00e9 impl\u00e9ment\u00e9e en France de fa\u00e7on syst\u00e9matique d\u00e8s 1998 ; elle permet une r\u00e9duction du nombre de leucocytes en dessous de 10 6 ",
            "cite_spans": [
                {
                    "start": 138,
                    "end": 139,
                    "text": "6",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "Techniques de d\u00e9leucocytation"
        },
        {
            "text": "Une pr\u00e9sentation plus ou moins exhaustive des diff\u00e9rentes m\u00e9thodes utilis\u00e9es pour inactiver de fa\u00e7on non sp\u00e9cifiques les agents infectieux pr\u00e9sents dans les PSL est disponible dans de nombreuses publications [3, 47, 49, [59] [60] [61] . Ces technologies ont l'avantage d'\u00eatre actives contre de nombreux agents, y compris ceux qui sont en \u00e9mergence.",
            "cite_spans": [
                {
                    "start": 208,
                    "end": 211,
                    "text": "[3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 212,
                    "end": 215,
                    "text": "47,",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 216,
                    "end": 219,
                    "text": "49,",
                    "ref_id": "BIBREF48"
                },
                {
                    "start": 220,
                    "end": 224,
                    "text": "[59]",
                    "ref_id": "BIBREF58"
                },
                {
                    "start": 225,
                    "end": 229,
                    "text": "[60]",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 230,
                    "end": 234,
                    "text": "[61]",
                    "ref_id": "BIBREF60"
                }
            ],
            "ref_spans": [],
            "section": "Inactivation non sp\u00e9cifique des pathog\u00e8nes"
        },
        {
            "text": "Les techniques d\u00e9di\u00e9es exclusivement au plasma comprennent : (i) des traitements physicochimiques comme l'utilisation de solvants-d\u00e9tergents capables d'inactiver les virus envelopp\u00e9s par destruction des lipides constitutifs de l'enveloppe, (ii) des traitements par des colorants \u00e0 base de ph\u00e9nothiazine comme le bleu de m\u00e9thyl\u00e8ne qui, lorsqu'ils sont photoactiv\u00e9s par la lumi\u00e8re visible, entra\u00eenent une oxydation de la guanine des g\u00e9nomes viraux, et (iii) des techniques physiques de nanofiltration qui \u00e9liminent les organismes de taille sup\u00e9rieure \u00e0 celle des pores du nanofiltre. Les deux premi\u00e8res techniques sont utilis\u00e9es en routine dans les centres de pr\u00e9paration de plasma en France.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Techniques d'inactivation pour le plasma"
        },
        {
            "text": "Trois techniques n\u00e9cessitant une photoactivation par des ultraviolets conviennent, avec des variantes, \u00e0 la fois au plasma et aux concentr\u00e9s plaquettaires ; il s'agit (i) du proc\u00e9d\u00e9 Intercept \u00ae de Cerus Corporation (Concord, Ca, \u00c9tats-Unis) qui utilise un d\u00e9riv\u00e9 du psoral\u00e8ne, l'amotosalen, comme principe actif, (ii) du proc\u00e9d\u00e9 Mirasol \u00ae de CaridianBCT Biotechnologies (Lakewood, Co, \u00c9tats-Unis) qui utilise la riboflavine (ou vitamine B2) comme principe actif, et (iii) du proc\u00e9d\u00e9 Theraflex UV \u00ae de MacoPharma (Tourcoing, France) qui, par la simple combinaison d'une irradiation par les ultraviolets et d'une intense agitation, produit la formation d'anneaux cyclobutyl. Ces proc\u00e9d\u00e9s sont actifs contre une large gamme de pathog\u00e8nes, incluant des virus nus et envelopp\u00e9s, des bact\u00e9ries et des protozoaires. Le rendement en plaquettes est sensiblement diminu\u00e9, notamment avec l'amotosalen, mais celles-ci semblent conserver leurs propri\u00e9t\u00e9s d'activation, d'adh\u00e9sion et d'agr\u00e9gation. Le syst\u00e8me Intercept \u00ae a \u00e9t\u00e9 test\u00e9 avec satisfaction pour l'inactivation des concentr\u00e9s plaquettaires lors de l'\u00e9pid\u00e9mie de CHIK-V \u00e0 la R\u00e9union.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Techniques d'inactivation convenant au plasma et aux concentr\u00e9s plaquettaires"
        },
        {
            "text": "Les proc\u00e9d\u00e9s d'inactivation des concentr\u00e9s de globules rouges font encore l'objet d'essais cliniques. Trois approches utilisant des agents bloquants des acides nucl\u00e9iques sont en cours d'\u00e9valuation assez avanc\u00e9e : la premi\u00e8re repose sur la riboflavine (Caridian), la deuxi\u00e8me sur une \u00e9thyl\u00e8neimine binaire, l'Inactine TM (PEN110) de la soci\u00e9t\u00e9 Vitex (Prestons, NSW, Australie), et la troisi\u00e8me sur un agent alkylant d\u00e9nomm\u00e9 S3003 ou amustaline (Cerus), dont l'activation ne se fait pas par irradiation mais par exposition \u00e0 un pH acide.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Techniques d'inactivation des concentr\u00e9s de globules rouges"
        },
        {
            "text": "Le rapport b\u00e9n\u00e9fice-risque de ces diff\u00e9rentes strat\u00e9gies d'inactivation fait l'objet d'\u00e9tudes dont les r\u00e9sultats seront bient\u00f4t publi\u00e9s.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Techniques d'inactivation des concentr\u00e9s de globules rouges"
        },
        {
            "text": "Au cours des 20 derni\u00e8res ann\u00e9es, la s\u00e9curit\u00e9 en transfusion sanguine a fait de tr\u00e8s grands progr\u00e8s vis-\u00e0-vis du risque infectieux et notamment du risque viral. L'am\u00e9lioration continue de la qualit\u00e9 conduit \u00e0 toujours accro\u00eetre la vigilance dans ce domaine. Si de tr\u00e8s nombreux virus peuvent \u00eatre consid\u00e9r\u00e9s comme \u00e9mergents, deux risques sont particuli\u00e8rement \u00e0 prendre en consid\u00e9ration en France m\u00e9tropolitaine : les arbovirus \u00e9mergents et l'agent de la MCJv.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusions"
        },
        {
            "text": "L'extension du p\u00e9rim\u00e8tre de diffusion d'Aedes albopictus en Europe justifie une surveillance accrue qui s'est mat\u00e9rialis\u00e9e par les recommandations de la circulaire n o DGS/RI1/2010/163 du 17 mai 2010 relative aux modalit\u00e9s de mise en oeuvre du plan anti-diss\u00e9mination du chikungunya et de la dengue en m\u00e9tropole [62] . Le faible nombre de cas transfusionnels r\u00e9pertori\u00e9s \u00e0 ce jour ne doit pas rassurer \u00e0 bon compte si l'on prend en consid\u00e9ration le fait que ces deux agents pourraient toucher des populations totalement r\u00e9ceptives ; \u00e0 cet \u00e9gard, l'implantation du WNV en Am\u00e9rique du nord et les nouveaux risques transfusionnels qui en ont d\u00e9coul\u00e9 peuvent servir de mod\u00e8le.",
            "cite_spans": [
                {
                    "start": 312,
                    "end": 316,
                    "text": "[62]",
                    "ref_id": "BIBREF61"
                }
            ],
            "ref_spans": [],
            "section": "Conclusions"
        },
        {
            "text": "En ce qui concerne le risque prion, m\u00eame s'il semble quantitativement faible, il justifie les efforts conjugu\u00e9s des sp\u00e9cialistes europ\u00e9ens pour d\u00e9velopper des outils de d\u00e9pistage fiables et performants de l'agent de la MCJv dans les produits sanguins.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusions"
        },
        {
            "text": "En parall\u00e8le, il appara\u00eet indispensable de d\u00e9velopper des traitements non sp\u00e9cifiques des PSL susceptibles d'inactiver les agents infectieux -quelle qu'en soit la nature -qui sont potentiellement pr\u00e9sents dans le sang des donneurs. Les essais en cours s'attachent \u00e0 \u00e9valuer le b\u00e9n\u00e9fice-risque de telles strat\u00e9gies afin de s'assurer que ces traitements n'alt\u00e8rent pas les propri\u00e9t\u00e9s des PSL et ne g\u00e9n\u00e8rent pas de nouveaux risques. Trouver un compromis entre le principe de pr\u00e9caution et celui de r\u00e9alit\u00e9 est bien le nouveau d\u00e9fi de la s\u00e9curit\u00e9 transfusionnelle pour les ann\u00e9es \u00e0 venir.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusions"
        },
        {
            "text": "Les auteurs n'ont d\u00e9clar\u00e9 aucun conflit d'int\u00e9r\u00eat sur les sujets discut\u00e9s.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conflit d'int\u00e9r\u00eat"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "S\u00e9curit\u00e9 des patients et analyse des causes racines",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Auroy",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Andreu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Aullen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Benhamou",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Caldani",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Canivet",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Trans Clin Biol",
            "volume": "17",
            "issn": "",
            "pages": "386--395",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Saint-Maurice : Institut national de veille sanitaire (INVS)",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Emerging infectious diseases that threaten the blood supply",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "J"
                    ],
                    "last": "Alter",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Stramer",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "Y"
                    ],
                    "last": "Dodd",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Sem Hematol",
            "volume": "44",
            "issn": "",
            "pages": "32--41",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Influence of blood prestorage conditions and white blood cell filtration on the bacterial load of blood deliberately inoculated with Gram-positive and Gram-negative pathogens",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Siblini",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Lafeuillade",
                    "suffix": ""
                },
                {
                    "first": "Ros",
                    "middle": [
                        "A"
                    ],
                    "last": "Garraud",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Pozzetto",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Vox Sang",
            "volume": "87",
            "issn": "",
            "pages": "241--250",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Emerging infectious disease agents and their potential threat to transfusion",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Stramer",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "B"
                    ],
                    "last": "Hollinger",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Katz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kleinman",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "S"
                    ],
                    "last": "Metzel",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Gregory",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Transfusion",
            "volume": "49",
            "issn": "",
            "pages": "1--29",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Lefr\u00e8re",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Hewitt",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Transfusion",
            "volume": "49",
            "issn": "",
            "pages": "797--812",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "An update of the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Turner",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Ludlam",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Br J Haematol",
            "volume": "144",
            "issn": "",
            "pages": "14--23",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Transmission of BSE by blood transfusion in sheep",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Houston",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "D"
                    ],
                    "last": "Foster",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Chong",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Hunter",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "J"
                    ],
                    "last": "Bostock",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Lancet",
            "volume": "356",
            "issn": "",
            "pages": "999--1000",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "A"
                    ],
                    "last": "Llewelyn",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Hewitt",
                    "suffix": ""
                },
                {
                    "first": "Rsg",
                    "middle": [],
                    "last": "Knight",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Amar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Cousens",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mackenzie",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Lancet",
            "volume": "363",
            "issn": "",
            "pages": "417--438",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "H"
                    ],
                    "last": "Peden",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "W"
                    ],
                    "last": "Head",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "L"
                    ],
                    "last": "Ritchie",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "E"
                    ],
                    "last": "Bell",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Ironside",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Lancet",
            "volume": "364",
            "issn": "",
            "pages": "527--59",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Clinical presentation and pre-mortem diagnosis of blood transfusion-associated variant CJD",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Wroe",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pal",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Siddique",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Hyare",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Macfarlane",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Joiner",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Lancet",
            "volume": "368",
            "issn": "",
            "pages": "2061--2068",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Fourth case of transfusion-associated vCJD infection in the United Kingdom",
            "authors": [],
            "year": 2007,
            "venue": "Euro Surveill",
            "volume": "12",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "Transmission of West Nile virus through blood transfusion in the United States in 2002",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "N"
                    ],
                    "last": "Pealer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Marfin",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "R"
                    ],
                    "last": "Petersen",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Lanciotti",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "L"
                    ],
                    "last": "Page",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Stramer",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "349",
            "issn": "",
            "pages": "1236--1281",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Transmission of West Nile virus from an organ transplant recipients",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Iwamoto",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "B"
                    ],
                    "last": "Jernigan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Guasch",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Trepka",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "G"
                    ],
                    "last": "Blackmore",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [
                        "C"
                    ],
                    "last": "Hellinger",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "348",
            "issn": "",
            "pages": "2196--203",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Cost-effectiveness of alternative bloodscreening strategies for West Nile virus in the United States",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "T"
                    ],
                    "last": "Korves",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "J"
                    ],
                    "last": "Goldie",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B"
                    ],
                    "last": "Murray",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "PLoS Med",
            "volume": "3",
            "issn": "",
            "pages": "211--232",
            "other_ids": {}
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Virus West Nile : \u00e0 nouveau en France chez l'homme et les chevaux",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Durand",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Simon",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Tolou",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Rev Prat",
            "volume": "54",
            "issn": "",
            "pages": "703--713",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Dengue virus in blood donations",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Mohammed",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Linnen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "Mu\u00f1oz-Jord\u00e1n",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Tomashek",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Foster",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Broulik",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Transfusion",
            "volume": "48",
            "issn": "",
            "pages": "1348--54",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Dengue viremia in blood donors from Honduras, Brazil, and Australia",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Linnen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Vinelli",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "C"
                    ],
                    "last": "Sabino",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "H"
                    ],
                    "last": "Tobler",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hyland",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "H"
                    ],
                    "last": "Lee",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Transfusion",
            "volume": "48",
            "issn": "",
            "pages": "1355--62",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Review of dengue fever cases in Hong Kong during",
            "authors": [
                {
                    "first": "Vwm",
                    "middle": [],
                    "last": "Chuang",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "Y"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "H"
                    ],
                    "last": "Leung",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "S"
                    ],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "L"
                    ],
                    "last": "Law",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "T"
                    ],
                    "last": "Tsang",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Hong Kong Med J",
            "volume": "14",
            "issn": "",
            "pages": "170--177",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Transfusion-Transmitted Dengue Infection study group. Dengue hemorrhagic fever transmitted by blood transfusion",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "A"
                    ],
                    "last": "Tambyah",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "S"
                    ],
                    "last": "Koay",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Poon",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "V"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "K"
                    ],
                    "last": "Ong",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "N Engl J Med",
            "volume": "359",
            "issn": "",
            "pages": "1526--1533",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Manille: The World Health Organization Regional Office for the Western Pacific (WPRO); \u00a9",
            "authors": [],
            "year": 2005,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Surveillance de la dengue aux Antilles. Le point \u00e9pid\u00e9miologique n o 2, 28 juillet",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Cire Antilles Guyane",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "First cases of autochthonous dengue fever and chikungunya fever in France: from bad dream to reality",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Gould",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gallian",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "De Lamballerie",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "N"
                    ],
                    "last": "Charrel",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Clin Microbiol Infect",
            "volume": "16",
            "issn": "",
            "pages": "1702--1706",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Estimation quantitative du risque de contamination d'un don de sang par le chikungunya lors de l'\u00e9pid\u00e9mie survenue \u00e0 La R\u00e9union",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Brouard",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bernillon",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Quatresous",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Pillonel",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Assal",
                    "suffix": ""
                },
                {
                    "first": "De",
                    "middle": [],
                    "last": "Valk",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "BEH",
            "volume": "18",
            "issn": "",
            "pages": "149--52",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "Centers for Disease Control and Prevention and National Institute of Health. Biosafety in microbiological and biomedical laboratories (BMBL) 5th Edition. Washington; US Government",
            "authors": [],
            "year": 2007,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "Novel Chikiungunya virus variant in travellers returning from Indian Ocean islands",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Parola",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "De Lamballerie",
                    "suffix": ""
                },
                {
                    "first": "Jourdan",
                    "middle": [
                        "J"
                    ],
                    "last": "Rovery",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Vaillant",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Minodier",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Emerg Infect Dis",
            "volume": "12",
            "issn": "",
            "pages": "1493--1502",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "Infection with Chikungunya virus in Italy: an outbreak in a temperate region",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Rezza",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Nicoletti",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Angelini",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Romi",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Finarelli",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Panning",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Lancet",
            "volume": "370",
            "issn": "",
            "pages": "1840--1846",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Tick-borne viral encephalitis in Finland. The clinical features of Kimlinge disease during 1959-1987",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Wahlberg",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Saikku",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Brummer-Korvenkontio",
                    "suffix": ""
                }
            ],
            "year": 1989,
            "venue": "J Intern Med",
            "volume": "225",
            "issn": "",
            "pages": "173--180",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Pellett",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "J"
                    ],
                    "last": "Wright",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "A"
                    ],
                    "last": "Engels",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "V"
                    ],
                    "last": "Ablashi",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Dollard",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Forghani",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Transfusion",
            "volume": "43",
            "issn": "",
            "pages": "1260--1268",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "Seroprevalence of human herpesvirus-8 in healthy human subjects and patients with AIDSassociated and classical Kaposi's sarcoma in France",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "G"
                    ],
                    "last": "Marcelin",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Dupin",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Bossi",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Calvez",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "AIDS",
            "volume": "12",
            "issn": "",
            "pages": "539--579",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Possible transmission of human herpesvirus-8 by blood transfusion in a historical United States cohort",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Dollard",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "E"
                    ],
                    "last": "Nelson",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "M"
                    ],
                    "last": "Ness",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Stambolis",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Kuehnert",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Pellett",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Transfusion",
            "volume": "45",
            "issn": "",
            "pages": "500--503",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Transmission of human herpesvirus 8 infection from renal-transplant donors to recipients",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Regamey",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tamm",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wernli",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Witschi",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Thiel",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Cathomas",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "N Engl J Med",
            "volume": "339",
            "issn": "",
            "pages": "1358--63",
            "other_ids": {}
        },
        "BIBREF32": {
            "ref_id": "b32",
            "title": "Transmission of human herpesvirus 8 by blood transfusion",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Hladik",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "C"
                    ],
                    "last": "Dollard",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Mermin",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "L"
                    ],
                    "last": "Fowlkes",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Downing",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "M"
                    ],
                    "last": "Amin",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "N Engl J Med",
            "volume": "355",
            "issn": "",
            "pages": "1331--1339",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "Parvovirus B19 transmission by a high-purity factor VIII concentrate",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "G"
                    ],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Mason",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Jong",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Erdman",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Mckernan",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Oakley",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Transfusion",
            "volume": "45",
            "issn": "",
            "pages": "1003--1013",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Clinical illness due to parvovirus B19 infection after infusion of solvent/detergent-treated pooled plasma",
            "authors": [
                {
                    "first": "U",
                    "middle": [
                        "F"
                    ],
                    "last": "Koenigbauer",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Eastlund",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "W"
                    ],
                    "last": "Day",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Transfusion",
            "volume": "40",
            "issn": "",
            "pages": "1203--1209",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Parvovirus B19 transmission by heat-treated clotting factor concentrates",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Blumel",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Schmidt",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Effenberger",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Seitz",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Willkommen",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "H"
                    ],
                    "last": "Brackmann",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Transfusion",
            "volume": "42",
            "issn": "",
            "pages": "1473--81",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "Transmission of hepatitis A via WBC-reduced RBCs and FFP from a single donation",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "H"
                    ],
                    "last": "Diwan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Stubbs",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "E"
                    ],
                    "last": "Carnahan",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Transfusion",
            "volume": "43",
            "issn": "",
            "pages": "536--576",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Silent transfusion-transmitted hepatitis A virus infection in an infant",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Garraud",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Conductier",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Odent-Malaure",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Carri\u00e8res",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chopart",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Brenas",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Transfusion",
            "volume": "44",
            "issn": "",
            "pages": "1121--1123",
            "other_ids": {}
        },
        "BIBREF38": {
            "ref_id": "b38",
            "title": "Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Gowland",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Fontana",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Niederhauser",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "M"
                    ],
                    "last": "Taleghani",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Transfusion",
            "volume": "44",
            "issn": "",
            "pages": "1555--61",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Matsubayashi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Nagoka",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Sakata",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sato",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Fukai",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kato",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Japan. Transfusion",
            "volume": "44",
            "issn": "",
            "pages": "934--974",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Transfusion-transmitted hepatitis E in a \"nonhyperendemic country",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Boxall",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Herborn",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Kocherthu",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Pratt",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Adams",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ijaz",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Transfus Med",
            "volume": "16",
            "issn": "",
            "pages": "79--83",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "H\u00e9patite E : maladie \u00e9mergente ?",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Nicand",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Bigaillon",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Tess\u00e9",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Pathol Biol",
            "volume": "57",
            "issn": "",
            "pages": "203--214",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Une h\u00e9patite \u00e9mergente : l'h\u00e9patite E",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "P\u00e9ron",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Mansuy",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Izopet",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Vinel",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Sant\u00e9",
            "volume": "16",
            "issn": "",
            "pages": "239--282",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "Hepatitis E: virus and chronic hepatitis in organ-transplant recipients",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kamar",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Selves",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Mansuy",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Ouezzani",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "P\u00e9ron",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guitard",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "N Engl J Med",
            "volume": "358",
            "issn": "",
            "pages": "811--818",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Legrand-Abravanel",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kamar",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Sandres-Saune",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Garrouste",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dubois",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "M"
                    ],
                    "last": "Mansuy",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "J Infect Dis",
            "volume": "202",
            "issn": "",
            "pages": "835--879",
            "other_ids": {}
        },
        "BIBREF45": {
            "ref_id": "b45",
            "title": "Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Pischke",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "V"
                    ],
                    "last": "Suneetha",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Baechlein",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Barg-Hock",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Heim",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kamar",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Liver Transpl",
            "volume": "16",
            "issn": "",
            "pages": "74--82",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Emerging infectious diseases agents and their potential threat to transfusion safety",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Stramer",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "B"
                    ],
                    "last": "Hollinger",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Katz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Kleinman",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [
                        "S"
                    ],
                    "last": "Metzel",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "R"
                    ],
                    "last": "Gregory",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Transfusion",
            "volume": "49",
            "issn": "",
            "pages": "1--29",
            "other_ids": {}
        },
        "BIBREF48": {
            "ref_id": "b48",
            "title": "Transfusiontransmitted infections",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Bihl",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Castelli",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Marincola",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "Y"
                    ],
                    "last": "Dodd",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Brander",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Transl Med",
            "volume": "5",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Gen\u00e8ve : Organisation mondiale de la sant\u00e9 (OMS) ; \u00a9",
            "authors": [],
            "year": 2011,
            "venue": "Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "Potential impact of pandemic influenza on blood safety and availability",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zou",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Transfus Med Rev",
            "volume": "20",
            "issn": "",
            "pages": "181--190",
            "other_ids": {}
        },
        "BIBREF51": {
            "ref_id": "b51",
            "title": "Emerging and re-emerging infections at the turn of the millennium",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "R"
                    ],
                    "last": "Zanetti",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zappa",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Haemophilia",
            "volume": "16",
            "issn": "",
            "pages": "7--12",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Preserving blood safety against emerging retroviruses",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Heneine",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kuehnert",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Transfusion",
            "volume": "46",
            "issn": "",
            "pages": "1276--1284",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Characterizing the threat to the blood supply associated with nonoccupational exposure to emerging simian retroviruses",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Schillaci",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Jones-Engel",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Engel",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Fuentes",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Transfusion",
            "volume": "48",
            "issn": "",
            "pages": "398--401",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Nucleic acid testing to detect HBV infection in blood donors",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Stramer",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Wend",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Candotti",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Foster",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "B"
                    ],
                    "last": "Hollinger",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "Y"
                    ],
                    "last": "Dodd",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "New Eng J Med",
            "volume": "364",
            "issn": "",
            "pages": "236--283",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Detection of prion infection in variant Creutzfeldt-Jakob disease: a bloodbased assay",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Edgeworth",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Farmer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Sicilia",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Tavares",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Beck",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Campbell",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Lancet",
            "volume": "377",
            "issn": "",
            "pages": "487--93",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Leukocyte reduction's role in the attenuation of infection risks among transfusion recipients",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Cervia",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Wenz",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "A"
                    ],
                    "last": "Ortolano",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Clin Infect Dis",
            "volume": "45",
            "issn": "",
            "pages": "1008--1021",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Gregori",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Mccombie",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Palmer",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Birch",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "O"
                    ],
                    "last": "Sowemimo-Coker",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Giulivi",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Lancet",
            "volume": "364",
            "issn": "",
            "pages": "529--560",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "The spectrum of safety: a review of the safety of current hemophilia products",
            "authors": [
                {
                    "first": "Nlc",
                    "middle": [],
                    "last": "Luban",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Sem Hematol",
            "volume": "3",
            "issn": "",
            "pages": "10--15",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Protecting the blood supply from emerging pathogens: the role of pathogen inactivation",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Blajchman",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Transfus Clin Biol",
            "volume": "16",
            "issn": "",
            "pages": "70--74",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "Alternative strategies in assuring blood safety: an overview",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Epstein",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Biologicals",
            "volume": "38",
            "issn": "",
            "pages": "31--36",
            "other_ids": {}
        },
        "BIBREF61": {
            "ref_id": "b61",
            "title": "DGS/RI1/2010/163 du 17 mai 2010 relative aux modalit\u00e9s de mise en oeuvre du plan anti-diss\u00e9mination du chikungunya et de la dengue en m\u00e9tropole. Disponible sur",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Conditions pour l'\u00e9mergence (ou la r\u00e9\u00e9mergence) r\u00e9elle ou apparente d'un virus ou d'un agent transmissible non conventionnel (prion).",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Principaux arbovirus pr\u00e9sentant un risque transfusionnel potentiel ou av\u00e9r\u00e9s. Dans la zone Europe, on assiste \u00e0 une recrudescence du nombre d'infections \u00e0 WNV, notamment en Europe centrale (Roumanie, Hongrie), en Russie, en Isra\u00ebl, en Turquie, en Gr\u00e8ce continentale (plus de 250 cas de formes neurologiques au cours de l'\u00e9t\u00e9 2010 dans la r\u00e9gion de Salonique) et m\u00eame en Italie. La France pr\u00e9conise une exclusion du don de sang, d'organes et de tissus de 28 jours pour tous les voyageurs revenant d'une zone o\u00f9 des cas humains symptomatiques sont signal\u00e9s. En 2003, des cas humains et \u00e9quins avaient \u00e9t\u00e9 observ\u00e9s dans le Sud de la France",
            "latex": null,
            "type": "table"
        },
        "TABREF2": {
            "text": "par unit\u00e9 de sang. Cette technique s'est av\u00e9r\u00e9e tr\u00e8s efficace pour \u00e9liminer les virus principalement intracellulaires et notamment le cytom\u00e9galovirus, le virus d'Epstein-Barr, HHV-8 et les r\u00e9trovirus (HIV et HTLV) [57]. La d\u00e9leucocytation permet aussi de minorer le risque prion d'un facteur d'environ 50 % [58], sans parler de son int\u00e9r\u00eat pour r\u00e9duire le risque d'immunisation HLA ou d'infection par des bact\u00e9ries ou des protozoaires.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}